PITX2 and breast carcinoma: In other cancers such as breast cancer and non small cell lung cancer, PITX2 is also predicted as a target of miR-21, [29, 30] strengthening the reliability of our predictions and our faith to validate these targeting relationships in the follow-up studies using dual-luciferase reporter assay.